跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03% - HSA Drug Approval Details
Approvals
/
HSA
/
LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03%
Approved
THERAPEUTIC
LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03%
Allergan Pharmaceuticals Ireland
🇸🇬 Health Sciences Authority
Approval Date
Jan 30, 2024
Approval ID
405b5612878d5424
Company
Allergan Pharmaceuticals Ireland
Type
Therapeutic
Approval Details
Approval Id
405b5612878d5424
Drug Name
LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03%
Product Name
LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03%
Approval Number
SIN16938P
Approval Date
2024-01-30
Registrant
ABBVIE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SOLUTION, STERILE
Route Of Administration
OPHTHALMIC
Atc Code
S01EE03
Atc Item Name
bimatoprost
Pharma Manufacturer Name
ABBVIE PTE. LTD.
Company Detail Path
/organization/abbvie-pte-ltd
Active Ingredients
Bimatoprost
0.3 mg/mL
Bimatoprost
0.3 mg/mL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 30, 2024
Approval ID
405b5612878d5424
Type
Therapeutic
Back to HSA Approvals
